Financials
Financial year 2025
Flex4Pharma from Overijse, company number BE0755383441, closed financial year 2025 with a result of € 18,711 after tax. For that financial year Flex4Pharma recorded a gross margin of € 27,525 and equity of € 30,751. Compared with financial year 2024, the result moved from € 718 to € 18,711. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 30,751
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 18,711
▲ € 17,993 vs 2024
Profit after tax over the fiscal year.
€ 4,273
Cash and bank balances on the last day of the fiscal year.
€ 15,000 paid out
80 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 48
▼ 90% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,688
Loans from banks and other lenders, long and short.
€ 6,677
▲ € 6,369 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,624
▲ € 2,324 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 39,332 | € -373 | € 674 | € 27,525 | ▲ € 26,851 |
| Profit after taxes | € 25,962 | € -1,794 | € 718 | € 18,711 | ▲ € 17,993 |
| Equity | € 28,116 | € 26,321 | € 27,040 | € 30,751 | ▲ 14% |
| Total debts | € 16,370 | € 4,971 | € 2,015 | € 28,760 | ▲ € 26,745 |
| Cash | € 20,484 | € 6,519 | € 4,255 | € 4,273 | |
| Retained profit | € 25,116 | € 23,321 | € 24,040 | € 27,751 | ▲ 15% |
| Dividend | € 0 | € 0 | € 0 | € 15,000 | |
| Bank debt | € 0 | € 0 | € 0 | € 1,688 | |
| Balance sheet total | € 44,486 | € 31,292 | € 29,055 | € 59,511 | ▲ 105% |
By gross margin, Flex4Pharma ranks 36th of 50 companies with main activity “Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen” in Flemish Brabant that publish figures (fiscal year 2025).
Key figures of Flex4Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Flex4Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Flex4Pharma?
What happened at Flex4Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18,711 (▲ € 17,993 vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Overijse. KBO
- Colette Huts became a director. NBB
In short
From € 25,962 profit in 2022 to € 18,711 profit in 2025.
Paid € 16,103 in corporate taxes since 2022.
Best year ever: 2022, with € 25,962 profit.
Paid out € 15,000 in dividends to the owners in total.
Management
Behind Flex4Pharma is Colette Huts. It owns 50% of Aixofit itself.
Directors
According to the 2025 annual accounts
since 2020
Establishments
Establishment units
Physical locations of this company
Akkerplein 7
3090 Overijse
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Flemish Brabant
Same main activity (Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen), 65 active companies in Flemish Brabant, largest first.
€ 125.9 million revenue · 2026 · Dilbeek
€ 47.6 million revenue · 2025 · Dilbeek
€ 36.4 million revenue · 2025 · Leuven
€ 9.8 million revenue · 2026 · Leuven
€ 7.7 million revenue · 2025 · Beersel
€ 2.3 million gross margin · 2023 · Asse
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- HUTS Colette Marie Alice(oprichter) 100%
Details
- Company number
- 0755.383.441
- VAT number
- BE 0755.383.441
- Registered office
- Akkerplein 7, 3090 Overijse
- Names & denominations
- Flex4Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 September 2020
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Activiteiten van holdings
Holdings